LexDanaLexDanabeta
Inventor

Zupeng XU

Inventor
CN

Overview

2→
Patents
2024–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides22%
G01NInvestigating or analysing materials by determining their chemical or physical properties22%
C12NMicroorganisms or enzymes11%
PatentTitleYear
12,227,583Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use202512,162,944Human IL-4R binding antibody, antigen binding fragment thereof, and medical use thereof2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2025Patents assigned to JIANGSU HENGRUI MEDICINE CO (2)· patent assignee history
2024Patents assigned to Shanghai hengrui pharmaceutical co ltd (1)· patent assignee history
2024–2025Based in CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JIANGSU HENGRUI MEDICINE CO22024–2025
Shanghai hengrui pharmaceutical co ltd12024
Locations
LocationPatentsSpan
CN22024–2025